Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The 20th Aspen Cancer Conference: Mechanisms of toxicity, carcinogenesis, cancer prevention, and cancer therapy 2005
    Journal Article

    Bishop, J. M.; Hanahan, D.; Tlsty, T.; Hunter, T.; Lowe, S.; Varmus, H.; Dornbush, K. T.; Waring, J. F.; Jacks, T.; Gilmer, T.; more...
    Molecular Carcinogenesis (2008)

    Fulltext@MSK | Save
  • Tris (dibenzylideneacetone) dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivo
    Journal Article

    Bhandarkar, S. S.; Bromberg, J.; Carrillo, C.; Selvakumar, P.; Sharma, R. K.; Perry, B. N.; Govindarajan, B.; Fried, L.; Sohn, A.; Reddy, K.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • Determinants of RASistance to anti-epidermal growth factor receptor agents
    Journal Article

    Baselga, J.; Rosen, N.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • The heat shock protein 90 chaperone complex: An evolving therapeutic target
    Journal Article

    Barginear, M. F.; Van Poznak, C.; Rosen, N.; Modi, S.; Hudis, C. A.; Budman, D. R.
    Current Cancer Drug Targets (2008)

    Fulltext@MSK | Save
  • HER kinase activation confers resistance to MET tyrosine kinase inhibition in MET oncogene-addicted gastric cancer cells
    Journal Article

    Bachleitner-Hofmann, T.; Sun, M. Y.; Chen, C. T.; Tang, L.; Song, L.; Zeng, Z.; Shah, M.; Christensen, J. G.; Rosen, N.; Solit, D. B.; more...
    Molecular Cancer Therapeutics (2008)

    Fulltext@MSK | Save
  • Epothilones in breast cancer: Current status and future directions
    Journal Article

    Atzori, F.; Fornier, M.
    Expert Review of Anticancer Therapy (2008)

    Fulltext@MSK | Save
  • Serum HER-2/neu and relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer
    Journal Article

    Ali, S. M.; Carney, W. P.; Esteva, F. J.; Fornier, M.; Harris, L.; KoĢˆstler, W. J.; Lotz, J. P.; Luftner, D.; Pichon, M. F.; Lipton, A.; more...
    Cancer (2008)

    Fulltext@MSK | Save
  • Preclinical testing of a novel regimen of capecitabine (C) in combination with bevacizumab (B) and trastuzumab (T) in a breast cancer xenograft model
    Meeting Abstract

    Traina, T. A.; Higgins, B.; Theodoulou, M.; Dugan, U.; Kolinsky, K.; Zhang, Y.; Heimbrook, D.; Packman, K.; Hudis, C.; Norton, L.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I study of a novel capecitabine schedule based on Norton-Simon mathematical modeling
    Meeting Abstract

    Theodoulou, M.; Traina, T. A.; Dugan, U.; Lake, D.; Fornier, M.; Feigin, K.; Patil, S.; Edwards, C.; Norton, L.; Hudis, C. A.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Bevacizumab 5mg/kg can be safely infused over 10 minutes
    Meeting Abstract

    Reidy, D. L.; Chung, K. Y.; Timoney, J. P.; Park, V.; Hollywood, E.; Sklarin, N.; Muller, R.; Saltz, L.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save